Ashutosh Shrivastava Selected Research

ON 013105

1/2013

Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashutosh Shrivastava Research Topics

Disease

7	Neoplasms (Cancer) 09/2021 - 10/2006
5	Breast Neoplasms (Breast Cancer) 09/2021 - 07/2006
2	Obesity 01/2022 - 01/2021
2	Glioma (Gliomas) 12/2021 - 10/2006
2	Carcinogenesis 01/2021 - 07/2006
2	Hypothyroidism 03/2009 - 10/2006
1	Insulin Resistance 01/2022
1	Glucose Intolerance 01/2022
1	Inflammation (Inflammations) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 12/2021
1	Astrocytoma (Pilocytic Astrocytoma) 12/2021
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Adenocarcinoma of Lung 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Infections 01/2019
1	Disease Progression 01/2019
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2013
1	Poliomyelitis (Polio) 04/2012
1	Residual Neoplasm 10/2011
1	Carcinoma in Situ 10/2011
1	Carcinoma (Carcinomatosis) 02/2011
1	Fibroadenoma 02/2011
1	Body Weight (Weight, Body) 05/2007
1	Hyperthyroidism 05/2007
1	Breast Diseases (Breast Disease) 07/2006

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
3	Estrogen ReceptorsIBA 09/2021 - 10/2011
3	EnzymesIBA 09/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
3	sodium-iodide symporter (sodium iodide symporter)IBA 01/2020 - 02/2011
3	Nerve Growth Factor (NGF)IBA 03/2009 - 10/2006
2	NucleotidesIBA 01/2022 - 01/2021
2	Tamoxifen FDA LinkGeneric 09/2021 - 01/2020
2	IodineIBA 10/2011 - 07/2006
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2009 - 05/2007
1	Insulin (Novolin)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 12/2021
1	Alkylating AgentsIBA 12/2021
1	MicroRNAs (MicroRNA)IBA 12/2021
1	Temozolomide (Temodar)FDA LinkGeneric 12/2021
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	SphingolipidsIBA 01/2021
1	CytokinesIBA 01/2021
1	sphingosine kinaseIBA 01/2021
1	LipidsIBA 01/2021
1	Hormones (Hormone)IBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	Iodide Peroxidase (Deiodinase)IBA 01/2020
1	Sigma-1 ReceptorIBA 01/2019
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2019
1	ON 013105IBA 01/2013
1	Rituximab (Mabthera)FDA Link 01/2013
1	VaccinesIBA 04/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2011
1	Beclin-1IBA 07/2011
1	Cytochromes c (Cytochrome c)IBA 07/2011
1	CannabinoidsIBA 07/2011
1	CannabidiolIBA 07/2011
1	Antineoplastic Agents (Antineoplastics)IBA 07/2011
1	Nerve Growth Factors (Neurotrophins)IBA 03/2009
1	NF-kappa B (NF-kB)IBA 03/2009
1	Caspase 3 (Caspase-3)IBA 05/2007
1	Death Domain ReceptorsIBA 05/2007
1	TransferasesIBA 05/2007
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 05/2007
1	LigandsIBA 05/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007
1	Caspase 8 (Caspase-8)IBA 05/2007
1	Fas Ligand Protein (Fas Ligand)IBA 05/2007
1	FenretinideIBA 10/2006
1	Methimazole (Thiamazole)FDA LinkGeneric 10/2006
1	RetinoidsIBA 10/2006
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2006
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 10/2006
1	Drinking WaterIBA 10/2006
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 07/2006
1	CaspasesIBA 07/2006

Therapy/Procedure

2	Therapeutics 12/2021 - 10/2011
1	Nutritional Support (Artificial Feeding) 09/2021
1	Mammaplasty (Breast Reconstruction) 02/2011
1	Injections 05/2007